GlassScriptPhysician profile
Phani Morisetti
NPI 1053756924
$9,175.45
in general payments reported to CMS, 2019-2025
28 companies · $1,496 in 2025
The $1,496 reported for 2025 was more than what 86% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $189 · 2021: $1,757 · 2022: $2,302 · 2023: $1,674 · 2024: $1,423 · 2025: $1,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,914 · Travel and Lodging: $563 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,914.35 |
| Travel and Lodging | $563.16 |
| Education | $116.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,059.09 | 2021-2025 | Ellipsys Vascular Access System, Concertotm, In.Pact Av |
| Mallinckrodt Hospital Products INC. | $851.78 | 2023-2025 | Acthar, Terlivaz |
| Otsuka America Pharmaceutical, INC. | $719.69 | 2019-2025 | Jynarque |
| Astrazeneca Pharmaceuticals LP | $568.82 | 2019-2025 | Lokelma, Farxiga |
| Calliditas Therapeutics US INC. | $332.47 | 2022-2025 | Tarpeyo |
| Amgen INC. | $302.15 | 2019-2025 | Tavneos |
| Inari Medical, INC. | $241.70 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Nxstage Medical, INC. | $234.47 | 2021-2024 | Nxstage System One |
| Alexion Pharmaceuticals, INC. | $219.43 | 2022-2025 | Soliris, Ultomiris |
| Glaxosmithkline, LLC. | $218.53 | 2022-2024 | Jesduvroq |
| Travere Therapeutics, INC. | $209.55 | 2023-2025 | |
| Daiichi Sankyo INC. | $173.62 | 2019-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $151.58 | 2021-2024 | |
| Okami Medical, INC. | $134.81 | 2025 | Lobo |
| Vifor Pharma, INC. | $131.71 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $98.95 | 2024-2025 | Azur Cx Detachable |
| Novartis Pharmaceuticals Corporation | $93.01 | 2025 | |
| Aurinia Pharma U.S., INC. | $87.42 | 2021-2023 | Lupkynis |
| Fresenius USA Marketing, INC. | $79.01 | 2019-2025 | Velphoro |
| Mozarc Medical US LLC | $49.55 | 2023-2024 | Chameleon, Argyle, Palindrome |
| Stryker Corporation | $47.02 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Opko Pharmaceuticals, LLC | $45.62 | 2019-2025 | Rayaldee |
| Argon Medical Devices, INC. | $28.40 | 2024 | Clot Management |
| Novo Nordisk INC | $24.38 | 2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.11 | 2024 | Jardiance |
| Becton, Dickinson and Company | $18.30 | 2024 | Covera |
| Amag Pharmaceuticals, INC. | $16.04 | 2020 | |
| Genzyme Corporation | $15.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phani Morisetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.